13-azaprostanoic acid has been researched along with 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid in 7 studies
Studies (13-azaprostanoic acid) | Trials (13-azaprostanoic acid) | Recent Studies (post-2010) (13-azaprostanoic acid) | Studies (15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid) | Trials (15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid) | Recent Studies (post-2010) (15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid) |
---|---|---|---|---|---|
42 | 0 | 0 | 2,577 | 27 | 327 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (71.43) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hamid-Bloomfield, S; Whittle, BJ | 1 |
Bertelé, V; Castagnoli, MN; Cerletti, C; de Gaetano, G; Rajtar, G | 1 |
Ghali, NI; Hung, SC; Kattelman, EJ; Le Breton, GC; Schnorf, KE; Venton, DL | 1 |
Burch, RM; Halushka, PV | 1 |
Le Breton, GC; Parise, LV; Venton, DL | 1 |
Ishikawa, M; Namiki, A | 1 |
Casonato, A; Deana, R; Francesconi, M; Girolami, A; Scapin, M | 1 |
7 other study(ies) available for 13-azaprostanoic acid and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid
Article | Year |
---|---|
Prostaglandin D2 interacts at thromboxane receptor-sites on guinea-pig platelets.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Animals; Blood Platelets; Guinea Pigs; Male; Organophosphonates; Organophosphorus Compounds; Platelet Aggregation; Prostaglandin D2; Prostaglandin Endoperoxides, Synthetic; Prostaglandins D; Prostanoic Acids; Receptors, Cell Surface; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides | 1986 |
Prostaglandins and human platelet aggregation. Implications for the anti-aggregating activity of thromboxane-synthase inhibitors.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Arachidonic Acid; Arachidonic Acids; Aspirin; Blood Platelets; Dinoprost; Dinoprostone; Drug Synergism; Humans; Imidazoles; Oxidoreductases; Platelet Aggregation; Prostaglandin D2; Prostaglandin Endoperoxides; Prostaglandin Endoperoxides, Synthetic; Prostaglandins; Prostaglandins D; Prostaglandins E; Prostaglandins F; Prostanoic Acids; Thromboxane B2; Thromboxane-A Synthase | 1985 |
Synthesis of [17,18-3H] trans-13-azaprostanoic acid. A labeled probe for the PGH2/TXA2 receptor.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Arachidonic Acid; Arachidonic Acids; Fatty Acids; Humans; In Vitro Techniques; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Prostanoic Acids; Receptors, Cell Surface; Receptors, Prostaglandin; Receptors, Thromboxane; Structure-Activity Relationship | 1984 |
45Ca fluxes in isolated toad bladder epithelial cells: effects of agents which alter water or sodium transport.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Alprostadil; Animals; Biological Transport; Body Water; Bufo marinus; Calcium; Cyclic AMP; Cyclooxygenase Inhibitors; Epithelium; Imidazoles; In Vitro Techniques; Prostaglandin Endoperoxides, Synthetic; Prostaglandins E; Prostanoic Acids; Sodium; Theophylline; Urinary Bladder; Vasopressins | 1983 |
Prostacyclin potentiates 13-azaprostanoic acid-induced platelet deaggregation.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Blood Platelets; Cyclic AMP; Drug Synergism; Epoprostenol; Fatty Acids; Humans; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Prostaglandins; Prostanoic Acids | 1982 |
The contractile mechanism of beraprost sodium, a stable prostacyclin analog, in the isolated canine femoral vein.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Animals; Dinoprost; Dogs; Dose-Response Relationship, Drug; Epoprostenol; Female; Femoral Artery; Femoral Vein; In Vitro Techniques; Male; Norepinephrine; Potassium; Prostaglandin Endoperoxides, Synthetic; Prostanoic Acids; Thromboxane A2; Vasoconstriction; Vasoconstrictor Agents | 1994 |
Adrenaline potentiates type 2B von Willebrand factor-induced activation of human platelets by enhancing both the formation and action of thromboxanes.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adrenergic alpha-Antagonists; Arachidonic Acid; Aspirin; Blood Platelets; Calcium; Drug Synergism; Epinephrine; Humans; Kinetics; Lipoxygenase; Phosphorylation; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin-Endoperoxide Synthases; Prostanoic Acids; Serotonin; Sympathomimetics; Thromboxanes; Tyrosine; Vasoconstrictor Agents; von Willebrand Factor; Yohimbine | 2000 |